- Home
- PENN vs ZLAB Comparison
PENN vs ZLAB Comparison
Compare PENN & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PENN
- ZLAB
- Stock Information
- Founded
- PENN 1972
- ZLAB 2013
- Country
- PENN United States
- ZLAB China
- Employees
- PENN N/A
- ZLAB N/A
- Industry
- PENN Hotels/Resorts
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- PENN Consumer Discretionary
- ZLAB Health Care
- Exchange
- PENN Nasdaq
- ZLAB Nasdaq
- Market Cap
- PENN 2.8B
- ZLAB 2.2B
- IPO Year
- PENN 1994
- ZLAB 2017
- Fundamental
- Price
- PENN $13.66
- ZLAB $19.93
- Analyst Decision
- PENN Buy
- ZLAB Buy
- Analyst Count
- PENN 18
- ZLAB 6
- Target Price
- PENN $21.94
- ZLAB $57.22
- AVG Volume (30 Days)
- PENN 4.0M
- ZLAB 920.9K
- Earning Date
- PENN 11-06-2025
- ZLAB 11-06-2025
- Dividend Yield
- PENN N/A
- ZLAB N/A
- EPS Growth
- PENN N/A
- ZLAB N/A
- EPS
- PENN N/A
- ZLAB N/A
- Revenue
- PENN $6,823,800,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- PENN $8.36
- ZLAB $40.71
- Revenue Next Year
- PENN $5.50
- ZLAB $50.42
- P/E Ratio
- PENN N/A
- ZLAB N/A
- Revenue Growth
- PENN 8.24
- ZLAB 24.14
- 52 Week Low
- PENN $13.24
- ZLAB $19.51
- 52 Week High
- PENN $23.08
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- PENN 30.96
- ZLAB 18.70
- Support Level
- PENN $13.45
- ZLAB $19.51
- Resistance Level
- PENN $14.56
- ZLAB $21.00
- Average True Range (ATR)
- PENN 0.84
- ZLAB 0.82
- MACD
- PENN -0.08
- ZLAB -0.03
- Stochastic Oscillator
- PENN 10.17
- ZLAB 6.21
About PENN PENN Entertainment Inc.
Penn Entertainment's origins date back to its 1972 racetrack opening in Pennsylvania. Today, Penn operates 43 properties across 20 states and 12 brands, including Hollywood Casino and Ameristar. Land-based casinos represented 85% of total sales in 2024; 15% was from the interactive segment, which includes sports, iGaming, and media revenue. The retail portfolio generates mid-30s EBITDAR margins and helps position the company to obtain licenses for the digital wagering markets. Additionally, Penn's media assets, theScore and ESPN (starting with its partnership launch in November 2023), provide access to sports betting/iGaming technology and clientele, helping it form a leading digital position.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.